Skip to main content

Table 2 Application of the proposed method to the determination of RIV and EDT in their raw materials

From: Bio-inspired one-pot synthesis of luminescent silver nanoparticles and its significant utility as a fluorescence nano sensor for analysis of two adjunctive COVID-19 drugs

Compound

Proposed method

Comparison method

At 333 nm

At 485 nm

Amount taken (μg/ml)

Amount found (μg/ml)

%Found*

Amount taken (μg/ml)

Amount found (μg/ml)

%Found*

Amount taken (μg/ml)

Amount found (μg/ml)

%Found*

Rivaroxaban

0.5

0.49

98.00

1

0.99

99.00

5

5.01

100.20

 

1

0.99

99.00

3

2.97

99.00

7

6.91

98.71

3

3.04

101.33

5

5.08

101.60

10

10.10

101.00

5

4.97

99.40

7

7.00

100.00

15

14.96

99.73

7

7.06

100.86

9

8.96

99.56

 

9

8.91

99.00

 

10

10.05

100.50

X− ± SD

 

99.72 ± 1.20

 

99.83 ± 1.07

 

99.91 ± 0.96

Student's t test

0.29 (2.26) **

0.11(2.36) **

 

Variance ratio (F test)

1.56(8.94) **

1.23(9.12) **

Edoxaban

0.5

0.50

100

0.7

0.69

98.57

4

4.03

100.75

1

0.99

99

 

1

1.000

100.00

2

2.00

100.00

6

5.99

99.83

3

2.99

99.67

3

3.01

100.33

10

10.06

100.60

5

4.98

99.60

5

5.00

100.00

 

7

7.07

101.00

7

6.98

99.71

9

8.90

98.88

 

10

10.05

100.50

X− ± SD

 

99.95 ± 0.68

 

99.60 ± 0.68

 

100.39 ± 0.49

Student's t test

1.11(2.26) **

1.23(2.45) **

 

Variance ratio (F test)

1.91(19.33) **

1.91(19.25) **

  1. *Each result is an average value of three separate determinations
  2. **Values between parentheses are the tabulated t and F values respectively, at p = 0.05